WallStreetZen

NASDAQ: ACCD
Accolade Inc Stock Forecast, Predictions & Price Target

Analyst price target for ACCD

Based on 9 analysts offering 12 month price targets for Accolade Inc.
Min Forecast
$33.00+30.64%
Avg Forecast
$55.44+119.49%
Max Forecast
$68.00+169.2%

Should I buy or sell ACCD stock?

Based on 9 analysts offering ratings for Accolade Inc.
Strong Buy
Strong Buy
5 analysts 55.56%
Buy
4 analysts 44.44%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ACCD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Jefferies
Top 17%
84
Strong BuyInitiates Coverage On$33.00+30.64%2021-12-02
Anonymous
Morgan Stanley
Strong BuyMaintains$56.00+121.69%2021-10-11
Credit Suisse
Bottom 3%
3
BuyMaintains$62.00+145.45%2021-10-08
Needham
Top 5%
96
BuyMaintains$56.00+121.69%2021-10-08
SVB Leerink
Top 37%
64
BuyMaintains$52.00+105.86%2021-10-08
Baird
Bottom 7%
7
BuyUpgrades$54.00+113.78%2021-09-17
Morgan Stanley
Top 5%
96
Strong BuyMaintains$68.00+169.20%2021-07-02
Piper Sandler
Bottom 9%
9
Strong BuyMaintains$60.00+137.53%2021-02-16
BTIG
Bottom 14%
14
Strong BuyInitiates Coverage On$55.00+117.74%2021-01-07
Canaccord Genuity
Bottom 17%
17
Strong BuyInitiates Coverage On$59.00+133.57%2020-12-08

1 of 1

Forecast return on equity

Is ACCD forecast to generate an efficient return?
Company
-10.45%
Industry
10.62%
Market
37.06%
ACCD's Return on Equity is forecast to be low in 3 years (-10.45%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ACCD forecast to generate an efficient return on assets?
Company
-6.04%
Industry
7.19%
ACCD is forecast to generate lower Return on Assets (-6.04%) than the US Health Information Services industry average (7.19%)
Forecast

ACCD earnings per share forecast

What is ACCD's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$1.88-20%
Avg 2 year Forecast
-$1.39-40.85%
Avg 3 year Forecast
-$1.15-51.06%

ACCD revenue forecast

What is ACCD's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$306.6M+33.01%
Avg 2 year Forecast
$401.5M+74.2%
Avg 3 year Forecast
$524.6M+127.61%
ACCD's revenue is forecast to grow at an exceptional rate of 30.95% per year
Forecast

ACCD revenue growth forecast

How is ACCD forecast to perform vs Health Information Services companies and vs the US market?
Company
30.95%
Industry
15.46%
Market
10.03%
ACCD's revenues are forecast to grow faster (30.95% per year) than the US Health Information Services industry average (15.46%)
Forecast
ACCD's revenues are forecast to grow faster (30.95% per year) than the US market average (10.03%)
Forecast

Accolade Stock Forecast FAQ

Is Accolade Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: ACCD) stock is to Strong Buy ACCD stock.

Out of 9 analysts, 5 (55.56%) are recommending ACCD as a Strong Buy, 4 (44.44%) are recommending ACCD as a Buy, 0 (0%) are recommending ACCD as a Hold, 0 (0%) are recommending ACCD as a Sell, and 0 (0%) are recommending ACCD as a Strong Sell.

What is ACCD's earnings growth forecast for 2022-2024?

(NASDAQ: ACCD) Accolade's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 14.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.37%.

Accolade's earnings in 2021 is -$132,392,000.On average, 3 Wall Street analysts forecast ACCD's earnings for 2022 to be $-125,328,670, with the lowest ACCD earnings forecast at $-139,994,791, and the highest ACCD earnings forecast at $-111,329,191. On average, 5 Wall Street analysts forecast ACCD's earnings for 2023 to be $-92,663,219, with the lowest ACCD earnings forecast at $-127,328,595, and the highest ACCD earnings forecast at $-71,330,679.

In 2024, ACCD is forecast to generate $-76,663,814 in earnings, with the lowest earnings forecast at $-127,328,595 and the highest earnings forecast at $-43,331,721.

What is ACCD's revenue growth forecast for 2022-2024?

(NASDAQ: ACCD) Accolade's forecast annual revenue growth rate of 30.95% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 15.46%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 10.03%.

Accolade's revenue in 2021 is $230,491,000.On average, 5 Wall Street analysts forecast ACCD's revenue for 2022 to be $20,438,039,472, with the lowest ACCD revenue forecast at $20,358,575,763, and the highest ACCD revenue forecast at $20,573,901,083. On average, 5 Wall Street analysts forecast ACCD's revenue for 2023 to be $26,766,603,978, with the lowest ACCD revenue forecast at $25,772,374,308, and the highest ACCD revenue forecast at $27,879,229,242.

In 2024, ACCD is forecast to generate $34,973,765,244 in revenue, with the lowest revenue forecast at $34,468,717,371 and the highest revenue forecast at $35,707,337,947.

What is ACCD's forecast return on assets (ROA) for 2022-2024?

(NASDAQ: ACCD) forecast ROA is -6.04%, which is lower than the forecast US Health Information Services industry average of 7.19%.

What is ACCD's Price Target?

According to 9 Wall Street analysts that have issued a 1 year ACCD price target, the average ACCD price target is $55.44, with the highest ACCD stock price forecast at $68.00 and the lowest ACCD stock price forecast at $33.00.

On average, Wall Street analysts predict that Accolade's share price could stay at $55.44 by Dec 2, 2022. The average Accolade stock price prediction forecasts a potential downside of N/A from the current ACCD share price of $25.26.

What is ACCD's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: ACCD) Accolade's current Earnings Per Share (EPS) is -$2.35. On average, analysts forecast that ACCD's EPS will be $-1.88 for 2022, with the lowest EPS forecast at $-2.10, and the highest EPS forecast at $-1.67. On average, analysts forecast that ACCD's EPS will be $-1.39 for 2023, with the lowest EPS forecast at $-1.91, and the highest EPS forecast at $-1.07. In 2024, ACCD's EPS is forecast to hit $-1.15 (min: $-1.91, max: $-0.65).

What is ACCD's forecast return on equity (ROE) for 2022-2024?

(NASDAQ: ACCD) forecast ROE is -10.45%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.